Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels

Gastroenterology

Volumn 117, Issue 2, 1999, Pages 414-419

  Guarner, C ^a   Sola, R ^a   Soriano, G ^a   Andreu, M ^a   Novella, M T ^a   Vila, M C ^a   Sabat, M ^a   Coll, S ^a   Ortiz, J ^a   Gomez, C ^a   Balanzo, J ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BILIRUBIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASCITES; ASCITES FLUID; BACTERIAL PERITONITIS; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; THROMBOCYTE COUNT;

EID: 0032806275     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.1999.0029900414     Document Type: Article

References (30)

1. C. Guarner B.A. Runyon Spontaneous bacterial peritonitis: pathogenesis, diagnosis, and management Gastroenterologist 3 1995 311 328
2. P. Gines A. Rimola R. Planas V. Vargas F. Marco M. Almela M. Forne M.L. Miranda J. Llach J.M. Salmeron J. Rodes Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial Hepatology 12 1990 716 724
3. G. Soriano C. Guarner M. Teixido J. Such J. Barrios J. Enriquez F. Vilardell Selective intestinal decontamination prevents spontaneous bacterial peritonitis Gastroenterology 100 1991 477 481
4. G. Soriano C. Guarner A. Tomas C. Villanueva X. Torras D. Gonzalez S. Sainz A. Anguera X. Cusso J. Balanzo F. Vilardell Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage Gastroenterology 103 1992 1267 1272
5. A. Rolachon L. Cordier Y. Bacq J.B. Nousbaum A. Franza J.C. Paris S. Fratte B. Bohn P. Kitmacher J.P. Stahl J.P. Zarski Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial Hepatology 22 1995 1171 1174
6. N. Singh T. Gayowski V.L. Yu M.M. Wagener Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial Ann Intern Med 122 1995 595 598
7. J.D. Grange D. Roulot G. Pelletier A. Pariente J. Denis O. Ink P. Blanc J.P. Richardet J.P. Vinel F. Delisle D. Fischer A. Flahault X. Amiot Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind, randomized trial J Hepatol 29 1998 430 436
8. P. Ginĕs M. Navasa Antibiotic prophylaxis for spontaneous bacterial peritonitis: how and whom? J Hepatol 29 1998 490 494
9. B.A. Runyon Management of adult patients with ascites caused by cirrhosis Hepatology 27 1998 264 271
10. M.J. Levy J.A. Dipalma New options for spontaneous bacterial prophylaxis: costly or cost effective? Am J Gastroenterol 91 1997 1050 1051
11. G. Garcia Tsao Spontaneous bacterial peritonitis Gastroenterol Clin North Am 21 1992 257 275
12. L. Tito A. Rimola P. Gines J. Llach V. Arroyo J. Rodes Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors Hepatology 8 1988 27 31
13. Ch. Silvain P.R. Mannant P. Ingrand E. Fort I. Besson M. Beauchant Recidive de l'infection spontanée du liquide d'ascite au curs de la cirrhose Gastroenterol Clin Biol 15 1991 106 109
14. A. Rimola J.M. Salmeron G. Clemente L. Rodrigo A. Obrador M.L. Miranda C. Guarner R. Planas R. Sola V. Vargas F. Casafont F. Marco M. Navasa R. Banares V. Arroyo J. Rodes Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis. Results of a prospective, randomized, multicenter study Hepatology 21 1995 674 679
15. M. Andreu R. Sola A. Sitges-Serra C. Alia M. Gallen M.C. Vila S. Coll M.I. Oliver Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites Gastroenterology 104 1993 1133 1138
16. M.T. Novella R. Solá G. Soriano M. Andreu J. Gana J. Ortiz S. Coll M. Sàbat M.C. Vila C. Guarner F. Vilardell Continuous versus in patient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin Hepatology 25 1997 532 536
17. J. Llach A. Rimola M. Navasa P. Gines J.M. Salmeron A. Gines V. Arroyo J. Rodes Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration Hepatology 16 1992 724 727
18. C. Dupeyron N. Mangeney L. Sedrati B. Campillo P. Fouet G. Leluan Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis Antimicrob Agents Chemother 38 1994 340 344
19. J. Ortiz M.C. Vila G. Soriano J. Miñana J. Gana B. Mirelis M.T. Novella S. Coll M. Sàbat M. Andreu G. Prats R. Solà C. Guarner Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients Hepatology 29 1999 1064 1069
20. B. Campillo C. Dupeyron J.P. Richardet N. Mangeney G. Leluan Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin Clin Infect Dis 26 1998 1066 1070
21. J.C. Hoefs B.A. Runyon Spontaneous bacterial peritonitis Dis Mon 31 1985 1 48
22. B.A. Runyon H.N. Canawati E.A. Akriviadis Optimization of ascitic fluid culture technique Gastroenterology 95 1988 1351 1355
23. A. Rimola F. Bory R. Planas A. Xaubet M. Bruguera J. Rodés Infecciones bacterianas agudas en la cirrosis hepática Gastroenterol Hepatol 4 1981 453 458
24. B.A. Runyon Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis Gastroenterology 91 1986 1343 1346
25. J. Such C. Guarner J. Enriquez J.L. Rodriguez I. Seres F. Vilardell Low C3 in ascitic fluid predisposes to spontaneous bacterial peritonitis J Hepatol 6 1988 80 84
26. G. Garcia-Tsao A. Escorsell M. Zakko D. Patch D. Matloff N. Grace A. Burroughs J. Bosch R.J. Groszmann Predicting the presence of significant portal hypertension and varices in compensated cirrhotic patients (abstr) Hepatology 26 1997 360A
27. C. Altman J.-D. Grange X. Amiot G. Pelletier F. Lacaine F. Bodin J.P. Etienne Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for or thotopic liver transplantation J Gastroenterol Hepatol 10 1995 47 50
28. D.J. Bac Spontaneous bacterial peritonitis: an indication for liver transplantation? Scand J Gastroenterol 31 suppl 218 1996 38 42
29. C. Guarner G. Soriano Spontaneous bacterial peritonitis Semin Liver Dis 17 1997 203 217
30. N. Chalasani N. Gitlin Incidence and risk factors for spontaneous bacterial peritonitis (SBP) in patients with chronic liver disease on the waiting list for orthotopic liver transplantation (OLT) (abstr) Hepatology 26 1997 491A